VYCO Stock Analysis
VY
Uncovered
Vycor Medical Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. The company is headquartered in Boca Raton, Florida. The company went IPO on 2009-03-31. The firm operates through two segments: Vycor Medical and NovaVision. The Company’s Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage. The firm designs, develops and markets neurological medical devices and therapies. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The firm operates in the United States and Europe.